XUHC.DE
Xtrackers MSCI USA Health Care UCITS ETF 1D
US
EQUITY
Passive
MANAGEMENT STYLE
€ 774.2 M
ASSETS UNDER MGMT
12 bp
EXPENSES
Fund Basics
| Inception date | Sep 12, 2017 |
| Regulation | UCITS |
| Fund Website | link... |
| Distributions | |
| Currency | EUR |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 14.2 % |
| JOHNSON & JOHNSON | 9.1 % |
| ABBVIE INC | 6.6 % |
| UNITEDHEALTH GROUP INC | 5.3 % |
| MERCK & CO. INC. | 4.8 % |
| THERMO FISHER SCIENTIFIC INC | 4.0 % |
| ABBOTT LABORATORIES | 3.7 % |
| INTUITIVE SURGICAL INC | 3.3 % |
| AMGEN INC | 3.0 % |
| DANAHER CORP | 2.7 % |
Constituent Breakdown
| Number of holdings | 59 |
| Herfindahl-Hirschman Index | 497 |
| Wgt avg mkt cap (mns) | $306,658 |
| Large cap (>$10bn) | 99.8% |
| Mid cap ($2-10bn) | 0.2% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 97.4 % |
 |
IRELAND | 2.6 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 0.3% | -5.0% | 0.0% | 3.8% | 7.0% | -- | -- | 8.4% |
| Dividend Yield | 0.0% | 0.7% | 1.0% | 1.1% | 1.5% | -- | -- | 1.3% |
| Total Returns | 0.3% | -4.3% | 1.0% | 4.9% | 8.5% | -- | -- | 9.6% | Ann. Volatility | 14.8% | 17.8% | 14.9% | 13.8% | 14.4% | -- | -- | 16.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | -0.05 | 0% |
| MSCI EAFE | -0.06 | 0% |
| MSCI Emg Mkts | -0.07 | 1% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $53.55 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.01/-0.05 |
| Bollinger Bands (Upper/Lower) | $54.11/$52.69 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XUHC.DE |
Expenses vs. XUHC.DE |
ALTAR Score™ vs. XUHC.DE |
|---|---|---|---|---|
| XUHL.DE | Xtrackers MSCI USA Health Care UCITS ETF 1C | 99.9% | 0 bp | -0.3% |
| IUHC.L | iShares S&P 500 Health Care Sector UCITS ETF | 95.8% | +3 bp | +0.3% |
| IUHE.AS | iShares S&P 500 Health Care Sector UCITS ETF | 95.8% | +6 bp | +0.3% |
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 70.9% | +13 bp | -0.1% |
| WELG.DE | Amundi S&P World Health Care Screened UCITS ETF Dist | 69.7% | +6 bp | -0.3% |
| WELS.DE | Amundi S&P World Health Care Screened UCITS ETF Acc | 69.7% | +6 bp | -0.2% |
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 61.4% | +6 bp | -0.5% |
| WHCS.AS | iShares MSCI World Health Care Sector Advanced UCITS ETF | 61.4% | +6 bp | -0.2% |
| XDG3.DE | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 47.4% | +23 bp | -0.7% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 25.5% | +28 bp | -4.3% |
Risk and Returns: XUHC.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (EUR)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.8%
ALTAR SCORE™
69th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,196 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. XUHC.DE's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places XUHC.DE in the 69th percentile
among funds in the category.
Sell-Side Consensus
€63.13
PRICE TARGET
+22.5%
UPSIDE